Related Experiment Video
Updated: Aug 17, 2026

TACI: An ImageJ Plugin for 3D Calcium Imaging Analysis
Published on: December 16, 2022
CTC-11 (Teijin)
1Division of Pharmacology, Department of Medicine and Care, Faculty of Health Sciences, Linköpings Universitet, SE-581 85, Linköping, Sweden. Per.Whiss@hul.liu.se
Abstract:
Teijin and Chemo-Sero are codeveloping CTC-111 as a treatment for disseminated intravascular coagulation (DIC) due to protein C deficiency. The drug was launched for the treatment of protein C deficiency in Japan on January 31, 2001 and as of October 2001 was awaiting approval for the treatment of DIC, also in Japan [426762]. CTC-111 was evaluated in a multicenter pharmacokinetic trial in venous thrombosis patients with inherited protein C deficiency. CTC-111 was effective in six of ten patients with venous thrombosis, six of seven patients with deep vein thrombosis and two of three patients with pulmonary embolism. Treatment was safe and effective and there were no serious adverse events [350149].
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Torque Free Motion
tRNA Activation
tRNA Activation
Steel Manufacturing
During this smelting process, limestone plays a crucial role by forming slag. Slag captures impurities within the molten iron, such...
Torque
Torque can be considered as the rotational counterpart to force. Since forces change the translational...

